Skip to Main Content

Try STAT+ TODAY

genetics

Most Read

Health Lauran Neergaard — Associated Press

Huge U.S. study starts sharing gene findings with volunteers

Biotech Megan Molteni

STAT Plus: ‘Make People Better’: The CRISPR babies story you probably don’t know, and how it was filmed in real-time

Health Andrew Joseph

STAT Plus: England to sequence genomes of 100,000 newborns, to try to catch illness earlier

Health Isabella Cueto

Revenge of the gaslit patients: Now, as scientists, they’re tackling Ehlers-Danlos syndromes

In the Lab Megan Molteni

On the long road to treating Huntington’s genetic stutter, scientists return to overlooked clues

In the Lab Megan Molteni

After three years in prison, ‘CRISPR babies’ scientist is attempting a comeback

Special Report Matthew Herper

Here’s why we’re not prepared for the next wave of biotech innovation

In the Lab Megan Molteni

Provocative new findings suggest a surprising cause of Down syndrome: cells linked to aging

All Coverage

Biotech Laura Ungar — Associated Press

STAT Plus: Promising gene therapy delivers treatment directly to brain

Biotech Jonathan Wosen

STAT Plus: Invitae’s new CEO on why the genetic testing firm stopped chasing ‘volume at all costs’

advertisement

Biotech Jonathan Wosen

STAT Plus: Upstart Element ratchets up race for cheaper DNA sequencing with a $200 genome

In the Lab Jonathan Wosen

Study offers a genetic explanation for why some drugs trigger a deadly brain disease

Biotech Ryan Cross — The Boston Globe

STAT Plus: mRNA startup Strand Therapeutics raises millions to test targeted cancer therapies

Biotech Megan Molteni

STAT Plus: Perfection is too high a bar for CRISPR treatments, says STAT Biomedical Innovation Award winner David Liu

Health Andrew Joseph

In a first, a fatal enzyme deficiency is treated in the womb

Biotech Usha Lee McFarling

STAT Plus: ‘Science is just rocketing forward’: A Q&A with former NIH director Francis Collins

Biotech Jonathan Wosen

STAT Plus: Pacific Biosciences, known for niche DNA sequencing, looks to rival Illumina with new product launch

Health Brittany Trang

Black Death may have influenced evolution of genes involved in immune responses, study finds

In the Lab Megan Molteni

Human neurons implanted in a rodent’s brain lead a rat to water — and make it drink

First Opinion Gigi Kwik Gronvall

STAT Plus: Needed: stricter screening of gene synthesis orders, customers

In the Lab Megan Molteni

Who will get the call from Stockholm? It’s time for STAT’s 2022 Nobel Prize predictions

Biotech Jonathan Wosen

STAT Plus: With rivals on its heels, Illumina launches a new line of high-end DNA sequencers

Biotech Jason Mast

STAT Plus: Biotech turns to new and strange viruses to overcome gene therapy’s limitations

Biotech Allison DeAngelis

STAT Plus: New CRISPR startup, drawing big-name backers, seeks to fix diseases caused by large DNA errors

First Opinion Sonia M. Suter and Laura Hercher

Dobbs decision is a huge setback for genetic counseling and the people who need it

First Opinion Pamela Feliciano

Genetic research provides new clarity about the ‘whys’ of autism

Health Emiliano Rodríguez Mega

A team of Oxford and Mexican researchers want to diversify genomic databases. Can they end ‘parachute science,’ too?

A STAT Investigation Allison DeAngelis, Adam Feuerstein and Jason Mast

STAT Plus: At pioneering center for gene therapy, Jim Wilson presided over toxic, abusive workplace, staffers say

In the Lab Elizabeth Cooney

New research digs into the genetic drivers of heart failure, with an eye to precision treatments

First Opinion David Reese and Kári Stefánsson

A better understanding of human diversity is needed to equitably advance precision medicine

Health Jonathan Wosen

STAT Plus: Genomics is racing toward a $100 genome. Are we ready for it?

Biotech Matthew Herper and Megan Molteni

STAT Plus: Verve Therapeutics begins human tests of first ‘base editor,’ aiming at heart disease

First Opinion Eric B. Kmiec

Secrecy: A demon of gene therapy’s past bedevils its future